The following presentations will be held in https://flipgrid.com/f86d186b:
Computational Drug Discovery for a Protease Inhibitor as a Treatment for the Coronavirus Disease
Gamma Crystallin Aggregation in the Presence of Disulfide Bond Forming (DBF) Enzyme
Aggregation of Gamma Crystallin Proteins
The Effect of Two Subsequent Purifications on DBF Using Immobilized Metal Affinity Column Chromatography
Novel drug design to inhibit the ZIKV NS2B-NS3 protease
Expression and Purification of DBF
Investigation Into Potential Inhibitors for Alpha-Synuclein
Computational Investigation of Potential Inhibitors for HIV Viral Infectivity Factor
Molecular Dynamics Investigation of Amyloid β Polyphenol Inhibitors in Alzheimer’s Disease
Computational Investigation of Polyphenols as Inhibitors to the Aggregation of Amyloid β in Alzheimer’s Disease
Computational Drug Design to Inhibit the Zika NS2B/NS3 Protease
Inhibition of DNA Deaminase APOBEC3B Using Computational Methods
Qualitative Study of the Chaperone Activity of DBF Enzyme on Protein Aggregates
Investigating Deprotonation of DNA Base Pairs by DNA Polymerase I in G. stearothermophilus Using QM/MM
Mutagenesis of Disulfide Bond Forming Enzyme
Computational Investigation of the Role of Polyphenol Drugs in the Disaggregation of Amyloid-Beta Plaques Associated with Alzheimer's Disease
Optimization of Bisintercalator Drug Modifications as a Treatment for Breast Cancer Utilizing Common Structural Drug Design Techniques and Molecular Dynamics
Optimization of the Aggregation of Gamma D Crystallin Protein
Synthesis of 1,1-methyl-sulfate-2-gamma-lactone-ol
Computational Drug Discovery of APOBEC3B Inhibitors as a Treatment for Epithelial Cancers
Modeling the Inhibition of Flavonoid Derivatives on Aromatase Using Molecular Dynamics
IN VITRO EFFECTS OF SALINITY AND NORDIHYDROGUAIARETIC ACID ON Aβ 1-28 AGGREGATION
Computational Chemistry Exploration of Inhibitors for APOBEC3B as a Potential Cancer Treatment